Healthcare analytics
Clinical quality reporting, outcomes, dashboards, Epic data, and validation.
Healthcare Data Analyst · Applied Biostatistics
Daniel Casillas, MPH
Denver, Colorado
I work with clinical, quality, and research data using SQL, SAS, R, Python, Epic, and Tableau. My background includes orthopedic quality improvement, clinical research, public health, and published academic work.
Biostatistics and research
Study design, SAS, R, regression, survival analysis, and scientific writing.
Reporting and data tools
SQL, Python, Tableau, Excel, REDCap, and reproducible workflows.
Experience
Healthcare and research
Quality Analyst, Orthopedic Surgery
Denver Health Medical Center
Healthcare quality analytics, outcomes reporting, dashboards, data validation, and quality initiatives.
Professional Research Assistant
University of Colorado Anschutz Medical Campus
Multi-site clinical research, regulatory compliance, data management, and scientific communication.
MPH, Applied Biostatistics
University of Colorado Anschutz Medical Campus
BS, Public Health
University of Colorado Denver
Training
Technical development
Epic training in progress
Expected October 2026Cogito Fundamentals · Clarity Data Model · Caboodle Data Model · Clinical Data Model
SQL reporting, healthcare data warehousing, clinical reporting, dashboards, data validation, and population health analytics.
DataCamp SQL coursework
CompletedIntroduction to SQL · Intermediate SQL
Filtering, aggregation, joins, subqueries, common table expressions, and data transformation.
Research
Publications
Casillas D, Bjornstad P, et al. Insulin Secretion, Sensitivity, and Kidney Function in Young Individuals With Type 2 Diabetes. Diabetes Care. 2024;47(3):409–417.
Casillas D, Bjornstad P, et al. Effects of Dapagliflozin on Sodium Excretion, Blood Pressure, and Volume Status in Patients With Type 2 Diabetes and/or Chronic Kidney Disease: The DAPASALT Trial. Diabetes, Obesity and Metabolism. 2025;27(8):4415–4426.
Casillas D, Caldwell-McGee A, et al. Obesity Drives Cardiac Hypertrophy while Diabetic Kidney Disease Links to Diastolic Dysfunction and Vascular Stiffness in Young Adults with Type 2 Diabetes. Diabetes. 2026;75(Supplement 1):1404-P.
Heerspink HJL, Casillas D, et al. Effects of Zibotentan, Dapagliflozin, and Their Combination on Kidney and Fluid Parameters in Individuals With Chronic Kidney Disease: A Randomized Double-Blind Placebo-Controlled Crossover Trial. Submitted to Kidney International, June 2026.
Selected work
Research posters
Public work only. Confidential or patient information is not posted.
Obesity Drives Cardiac Hypertrophy while Diabetic Kidney Disease Links to Diastolic Dysfunction and Vascular Stiffness in Young Adults with Type 2 Diabetes
Research poster | Co-author
Download PowerPoint
Effects of Zibotentan, Dapagliflozin, and Their Combination on Albuminuria and Fluid Parameters in Individuals With Chronic Kidney Disease
Research poster | Co-author and presenter
View PDF
Evaluation of Racial and Ethnic Differences in Glucose and Lipid Metabolism and Impact on Neonatal Growth Outcomes among Women with Gestational Diabetes
Research poster
View PDFInteractive project
Hunger Games SQL playground
Practice SELECT, WHERE, GROUP BY, and JOIN queries with tribute and arena data.
Clinical analytics toolkit
Clinical Statistics Workbench
Choose tests, calculate effect estimates, check clinical dates, profile deidentified data, build Table 1 summaries, and draft methods.
Featured
Profiles and media
Contact